Peripheral Vascular Stents Market Size & Growth Forecast 2027–2036, By Segments (Mode of Delivery, Type, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Peripheral Vascular Stents Market size was worth USD 4 Billion in 2026 and is poised to grow at a 8.08% CAGR between 2027 and 2036, exceeding USD 8.7 Billion by 2036. The industry revenue for 2027 is assessed at USD 4.27 Billion.
Get more details on this report
Request Free Sample ReportPeripheral Vascular Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 46.42% share, driven by high diagnosis rates, established minimally invasive treatment pathways, and strong interventional vascular infrastructure across care centers.
- Asia Pacific is growing at 8.48% CAGR due to expanding vascular care access, increasing procedural volumes, and broader adoption of endovascular interventions in developing healthcare systems.
Segment Momentum
- Balloon-expandable Stents captured 56.62% of the market in 2026, supported by their reliable deployment accuracy and predictable vessel scaffolding in routine peripheral vascular procedures.
- Bioabsorbable Stents are the fastest-growing type segment because demand is increasing for temporary vessel support that reduces long-term implanted material while supporting the healing process.
Market Expansion Drivers
- Rising prevalence of peripheral arterial diseases increasing demand for vascular interventions.
- Expanding aging population driving higher incidence of vascular occlusions and PAD cases.
- Advancements in minimally invasive stent technologies improving procedural success and recovery outcomes.
Leading Market Participants
- Key companies in the peripheral vascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Cook Medical LLC (United States), Cordis Corporation (United States), MicroPort Scientific Corporation (China), iVascular S.L.U. (Spain), Lifetech Scientific Corporation (China), Becton, Dickinson and Company (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 4 Billion
- 2027 Estimated Market Size: USD 4.27 Billion.
- Projected Market Size: USD 8.7 Billion by 2036
- Growth Forecast: 8.08% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Balloon-expandable Stents (Mode of Delivery) | Drug Eluting Stents (DES) (Type) | Hospitals & Cardiac Centers (End-use) | Iliac Artery Stents (Product)
- Emerging Opportunity Segment: Self-expanding Stents (Mode of Delivery) | Bioabsorbable Stents (Type) | Ambulatory Surgical Centers (End-use) | Carotid Artery Stents (Product)
Market Growth Drivers and Industry Trends
Rising prevalence of peripheral arterial diseases increasing demand for vascular interventions
The peripheral vascular stents market is expanding as peripheral arterial disease and related circulatory disorders create greater demand for interventions that restore blood flow to affected limbs. Stent implantation can provide mechanical support to narrowed or obstructed peripheral vessels following angioplasty, helping maintain vessel patency in appropriate patients. Increased disease recognition and broader use of endovascular treatment are also encouraging clinicians to consider minimally invasive vascular interventions before more invasive procedures are required.
Expanding aging population driving higher incidence of vascular occlusions and PAD cases
An expanding elderly population is contributing to a greater burden of peripheral vascular conditions because vascular disease becomes more common with advancing age and is often accompanied by other chronic health risks. Within the peripheral vascular stents market, the increasing number of older patients requiring management of arterial narrowing and occlusions is creating sustained demand for devices used in endovascular revascularization procedures. Treatment planning for older patients also places emphasis on less invasive approaches that can address vascular obstruction while limiting procedural burden and supporting recovery.
Advancements in minimally invasive stent technologies improving procedural success and recovery outcomes
Innovation in peripheral stent design is improving the ability of physicians to navigate complex vascular anatomy and maintain vessel support following intervention. The peripheral vascular stents market is gaining from developments in flexible materials, delivery systems, stent architecture, and deployment mechanisms that can improve positioning and adaptability within peripheral vessels. These advances support more precise endovascular procedures and can help reduce procedural trauma, enabling patients to undergo vascular treatment through catheter-based approaches with shorter recovery requirements than conventional surgical alternatives.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of peripheral arterial diseases increasing demand for vascular interventions | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Expanding aging population driving higher incidence of vascular occlusions and PAD cases | 1.70% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Advancements in minimally invasive stent technologies improving procedural success and recovery outcomes | 1.50% | High | North America, Europe | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the peripheral vascular stents market, North America held the largest share of 46.42% in 2026, driven by advanced vascular care systems, strong adoption of minimally invasive interventions, and widespread availability of specialized treatment facilities. The region benefits from established clinical pathways for diagnosing and managing peripheral vascular conditions, enabling timely access to endovascular procedures. High healthcare expenditure and the presence of sophisticated imaging and interventional infrastructure further support the use of stent technologies. Ongoing emphasis on improving patient outcomes through less invasive treatment options and continued technological advancement strengthens North America's position in the market.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region as healthcare systems expand their capacity to provide advanced vascular interventions. Rising awareness of peripheral vascular conditions, improving diagnostic access, and increasing investment in modern hospitals and interventional facilities are supporting market development. Greater availability of minimally invasive treatment options is encouraging adoption among healthcare providers and patients, while expanding healthcare coverage in parts of the region is improving access to specialized procedures. These factors, combined with growing demand for advanced vascular care, are expected to sustain the region's strong growth momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Endovascular Procedure ExcellenceGermany maintains strong adoption of endovascular therapies supported by experienced vascular specialists. The peripheral vascular stents market prioritizes durable products designed for procedural precision and reliable clinical performance across diverse treatment settings.
France 🇫🇷
Structured Clinical AdoptionFrance integrates peripheral vascular stents through established treatment protocols emphasizing clinical effectiveness and patient safety. Manufacturers serving France benefit from demonstrating robust evidence, product reliability, and compatibility with routine vascular intervention practices.
Italy 🇮🇹
Expanding Peripheral InterventionItaly is increasing the use of endovascular procedures across hospitals managing peripheral vascular diseases. The peripheral vascular stents market supports demand for dependable technologies that simplify intervention while addressing a growing need for minimally invasive treatment options.
Japan 🇯🇵
Minimally Invasive PreferenceJapan continues expanding minimally invasive vascular interventions to address the needs of an aging patient population. The peripheral vascular stents market favors compact, high-performance devices that enhance treatment precision while supporting efficient post-procedure recovery.
South Korea 🇰🇷
Technology-Driven Vascular CareSouth Korea encourages adoption of advanced vascular intervention technologies through modern healthcare infrastructure. The peripheral vascular stents market benefits from demand for innovative devices that improve treatment flexibility and support high-quality clinical outcomes.
United States 🇺🇸
Complex Vascular SolutionsThe U.S. peripheral vascular stents market is driven by increasing use of minimally invasive procedures for peripheral artery disease. Healthcare providers seek versatile stent technologies that address complex vascular conditions while supporting efficient intervention and long-term patient care.
Segment Leadership and Growth Trends
Peripheral Vascular Stents Market Share (%), by Mode of Delivery, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMode of Delivery Segment Analysis: Balloon-expandable Stents (Largest Segment) vs Self-expanding Stents (Fastest-Growing Segment)
Balloon-expandable stents accounted for the largest share of the peripheral vascular stents market, representing 56.62% in 2026, owing to their strong radial support and high deployment precision. These characteristics make them suitable for peripheral lesions where accurate positioning and controlled expansion are important, while established procedural familiarity continues to support their use among vascular specialists.
Self-expanding stents are anticipated to achieve the fastest growth during the forecast period, supported by their flexibility and capacity to adapt to vessel movement and anatomical variations. Their suitability for complex peripheral vascular lesions, particularly in vessels exposed to bending and compression, is increasing their relevance as minimally invasive vascular interventions continue to evolve.
Type Segment Analysis: Drug Eluting Stents (DES) (Largest Segment) vs Bioabsorbable Stents (Fastest-Growing Segment)
The drug eluting stents (DES) segment led the peripheral vascular stents market with a 58.7% share in 2026, driven by the value of localized drug delivery in limiting tissue proliferation and supporting vessel patency. Growing emphasis on improving treatment durability and reducing the likelihood of restenosis has sustained demand for drug-eluting technologies in peripheral vascular procedures.
Bioabsorbable stents are expected to grow at the fastest rate during the forecast period, reflecting increasing interest in temporary vascular scaffolding that can gradually disappear after serving its therapeutic purpose. Advancements in biodegradable materials and stent engineering, coupled with interest in minimizing long-term implant-related considerations, are creating greater opportunities for this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Mode of Delivery | Self-expanding Stents, Balloon-expandable Stents | Balloon-expandable Stents | Self-expanding Stents |
| Type | Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents | Drug Eluting Stents (DES) | Bioabsorbable Stents |
| End-use | Hospitals & Cardiac Centers, Ambulatory Surgical Centers, Others | Hospitals & Cardiac Centers | Ambulatory Surgical Centers |
| Product | Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, Others | Iliac Artery Stents | Carotid Artery Stents |
Competitive Landscape and Market Positioning
Key companies in the peripheral vascular stents market:
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Terumo Corporation (Japan)
4. BIOTRONIK SE & Co. KG (Germany)
5. Cook Medical LLC (United States)
6. Cordis Corporation (United States)
7. MicroPort Scientific Corporation (China)
8. iVascular S.L.U. (Spain)
9. Lifetech Scientific Corporation (China)
10. Becton Dickinson and Company (United States)
Continuous improvement in vascular intervention techniques is shaping the peripheral vascular stents market, with innovation centered on flexibility and procedural efficiency. Enhanced material science is enabling better adaptability to complex anatomies. The peripheral vascular stents market is advancing toward more precise and patient-specific solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| BIOTRONIK SE & Co. KG (Germany) | |||||||
| Cook Medical LLC (United States) | |||||||
| Cordis Corporation (United States) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| iVascular S.L.U. (Spain) | |||||||
| Lifetech Scientific Corporation (China) | |||||||
| Becton Dickinson and Company (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Medtronic | 2025 | Medtronic introduced advanced self-expanding nitinol stent systems designed with enhanced flexibility and vessel patency performance. These next-generation stents target the challenges of peripheral artery disease, providing clinicians with improved deliverability and long-term structural integrity in tortuous anatomy, which enhances the company's competitive position in the peripheral interventional market. |
| Biotronik | 2025 | Biotronik launched next-generation bioabsorbable vascular scaffold technologies for minimally invasive cardiovascular and peripheral therapies. By advancing its bioresorbable platform, the company is targeting the shift toward temporary support structures that dissolve after vessel healing, offering a strategic alternative to permanent metallic implants and addressing a key segment of the vascular intervention market. |
| Boston Scientific | 2024 | Boston Scientific expanded its peripheral drug-eluting stent portfolio, specifically optimizing designs for femoropopliteal artery treatment. This product enhancement focuses on improving clinical outcomes in high-complexity vascular cases, reflecting the company’s strategic commitment to maintaining its market leadership through continuous innovation in specialized peripheral vascular devices. |
| Terumo Medical | 2024 | Terumo Medical launched a new series of low-profile catheter delivery systems specifically engineered for complex peripheral artery disease procedures. This development focuses on enhancing physician control and procedural access in challenging vascular environments, reinforcing Terumo’s competitive strategy in peripheral vascular intervention by improving the ease and precision of stent delivery. |
| Cordis | Oct-23 | Cordis completed the acquisition of MedAlliance in a landmark transaction valued at up to USD 1.135 billion. By integrating MedAlliance’s proprietary SELUTION SLR sustained-release sirolimus drug-eluting balloon technology, Cordis has significantly bolstered its peripheral vascular portfolio, positioning the company to address the treatment of complex peripheral artery disease with a differentiated, stentless therapeutic platform. |
| Abbott | 2023 | Abbott expanded its vascular imaging integration technologies to support precision-guided peripheral interventions. By integrating advanced imaging capabilities with its stent and catheter systems, the company provides physicians with real-time, high-fidelity visualization, enabling more accurate stent placement and better long-term outcomes in peripheral vascular procedures. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Peripheral Vascular Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Indication | Peripheral Artery Disease, Carotid Artery Disease, Renal Artery Disease, Other Peripheral Vascular Disorders |
| Lesion Complexity | Simple Lesions, Moderate-Complexity Lesions, Complex Lesions, Chronic Total Occlusions |
| Procurement Channel | Direct Manufacturer Sales, Distributor & Wholesaler Sales, Group Purchasing Organizations, Government & Institutional Procurement |
Peripheral Vascular Stents Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Peripheral Intervention Adoption and Procedure Trends |
|
| Limb Preservation Market Opportunity Assessment |
|
| Peripheral Vascular Care Infrastructure Readiness |
|
Need a different cut of the data?
Request Custom ResearchHow big is the peripheral vascular stents market?
What is the expected industry size of peripheral vascular stents by 2036?
What is driving earlier adoption of peripheral vascular stents in treatment pathways?
How are technological improvements shaping procedural success in peripheral stenting?
Why do Balloon-expandable Stents hold the largest share of the peripheral vascular stents market?
Which type segment is expanding the fastest in the peripheral vascular stents market?
Why is North America the leading region in the peripheral vascular stents market?
What factors are driving growth in the Asia Pacific peripheral vascular stents market?
Who are the major participants shaping the peripheral vascular stents landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization